IRCT20220616055195N1RecruitingPhase 3
The effect of Dorema ammoniacum topical ointment on mild to moderate plaque psoriasis
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Enrollment
- 64
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 12 years to no limit (—)
- Sex
- All
Inclusion Criteria
- •Chronic plaque form psoriasis patients
- •Plaque size : lower than 10 %
- •Age : older than 12 years old
Exclusion Criteria
- •Taking topical medicine in the last 14 days and systemic drug in the 30 last days
- •Pregnancy or planning to be pregnant or breast feeding
- •History of allergy to herbal medicines
- •Presence of abnormal laboratory finding
- •Taking local or systemic medicine that has a positive or negative effect on the course of the disease
- •Having serious liver or kidney disease
Investigators
Similar Trials
Recruiting
Phase 3
Effect of Dorema Ammoniacum Cream on the prevention of peripheral intravenous catheter-related phlebitis In patients admitted to surgery departmentsPhlebitis.Phlebitis and thrombophlebitis of other sites180.8IRCT20201119049441N1Tehran University of Medical Sciences110
Completed
Phase 3
Farfioun Effects on OsteoarthritisOsteoarthritis of kneeIRCT20210916052501N1Mazandaran University of Medical Sciences25
Not yet recruiting
Phase 3
Dermaheal Effect on Diabetic Foot UlcerIRCT20080904001199N4Darudarman Salafchegan Co. (Knowledge-based)50
Completed
Phase 2
Effect of Rosmarinus ointment on phlebitisphlebitis.Other disorders of circulatory system in diseases classified elsewhereIRCT2016021914930N5Vice chancellor for Research of Ahvaz Jundishapur University of Medical Sciences46
Completed
Phase 3
Effect of hydroalcoholic extract of Ruscus hyrcanus in treatment of chronic venous insufficiencyIRCT20100107003014N20Vice chancellor for research and technology, Mazandaran University of Medical Sciences60